Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity

Kidney International

Volumn 68, Issue 3, 2005, Pages 1312-1319

  Chang, Chi Jen ^b   Ko, Yu Shien ^b   Ko, Po Jen ^b   Hsu, Lung An ^b   Chen, Chin Fen ^b   Yang, Chih Wei ^b   Hsu, Tsu Shiu ^b   Pang, Jong Hwei S ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NONE

Author keywords

Hemodialysis vascular access; Inflammation; Thrombosis

Indexed keywords

GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMODIALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; STENOSIS; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTERIOVENOUS SHUNT, SURGICAL; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LYMPHOCYTES; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; RENAL DIALYSIS; THROMBOSIS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 29244490870     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00529.x     Document Type: Article

References (35)

1. FELDMAN HI, KOBRIN S, WASSERSTEIN A: Hemodialysis vascular access morbidity. J Am Soc Nephrol 7:523-535, 1996
2. FELDMAN HI, HELD PJ, HUTCHINSON JT, et al: Hemodialysis vascular access morbidity in the United States. Kidney Int 43:1091-1096, 1993
3. U.S. RENAL DATA SYSTEM: X. The cost effectiveness of alternative types of vascular access and the economic cost of ESRD. Am J Kidney Dis 26:S140-S156, 1995
4. CARLSTON DM, DUNCAN DA, NAESSENS JM, JOHNSON WJ: Hospitalization in dialysis patients. Mayo Clin Proc 59:769-775, 1984
5. SCHWAB SJ, BESARAB A, BEATHARD G, et al: National Kidney Foundation DOQI Clinical Practice Guidelines for Hemodialysis Vascular Access Working Group. Am J Kidney Dis 30 (Suppl 3):S154-S196, 1997
6. FAN PY, SCHWAB SJ: Vascular access: Concepts for 1990s. J Am Soc Nephrol 3:1-11, 1992
7. WINDUS DW: Permanent vascular access: A nephrologist's view. Am J Kidney Dis 21:457-451, 1993
8. MUNDA R, FIRST R, ALEXANDEER JW, et al: Polytetrafuoroethlene graft survival in hemodialysis. JAMA 249:219-222, 1983
9. SCHWAB SJ, RAYMOND JR, SAEED M, et al: Prevention of hemodialysis fistula thrombosis: Early detection of venous stenosis. Kidney Int 36:707-711, 1989
10. HODGES T, FILLINGER M, ZWOLAK R, et al: Longitudinal comparison of dialysis access methods: Risk factors for failure. J Vasc Surg 26:1009-1019, 1997
11. OAKES D, SHERCK J, COBB L: Surgical salvage of failed radiocephalic fistulae: Techniques and results in 29 patients. Kidney Int 53:480-487, 1998
12. TURMEL-RODRIGUES L, PENGLOAN J, RODRIGUE H, et al: Treatment of failed native arteriovenous fistulae for hemodialysis by interventional radiology. Kidney Int 57:1124-1140, 2000
13. OVERBOSCH EH, PATTYNAMA PM, AARTS HJ, et al: Occluded hemodialysis shunts: Dutch multicenter experience with the hydrolyser catheter. Radiology 201:485-488, 1996
14. LIBBY P: The molecular bases of the acute coronary syndrome. Circulation 99:1726-1732, 1995
15. LEE R, LIBBY P: The unstable atheroma. Arterioscler Thromb Vasc Biol 17:1859-1867, 1997
16. WAKEFIELD TW, STRIETER RM, WILKE CA, et al: Venous thombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioslcel Thromb Vasc Biol 15:258-268, 1995
17. ROUMEN-KLAPPE EM, HEIJER MD, VAN UUM SHM, et al: Inflammatory response in the acute phase of deep vein thrombosis. J Vasc Surg 35:701-706, 2002
18. TSAI AW, CUSHMAN M, ROSMOND WD, et al: Coagulation factors, inflammation markers, and venous thromboembolism: The longitudinal investigation of thromboembolism etiology (LITE). Am J Med 113:636-642, 2002
19. MYERS D, WROBLESKI S, LONDY F, et al: New and effective treatment of experimentally induced venous thrombosis with anti-inflammatory rPSGL-ig. Thrombosis 87:374-382, 2002
20. CHURCHILL DN, TAYLOR DW, COOK RJ, et al: Canadian Hemodialysis Morbidity Study. Am J Kidney Dis 19:214-234, 1992
21. STENVINKEL P, HEIMBURGER O, PAULTRE F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
22. KAYSEN GA, DUBIN JA, MULLER HG, et al: The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int 58:346-352, 2000
23. KAYSEN GA, DON BR: Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease. Kidney Int 63 (Suppl 84):S94-S97, 2003
24. BOLOGA RM, LEVINE DM, PARKER TS, et al: Interleukin-6 predicts hypoalbuminemia, hypocholestremia, and mortality in hemidialysis patients. Am J Kidney Dis 32:107-114, 1998
25. GALIS ZS, SUKHOVA GK, LARK MW, LIBBY P: Increased expression of matrix metalloproteinase and matrix degrading activity in vulnerable regions of human atherosclerotic plaque. J Clin Invest 94:2493-2503, 1994
26. LI Z, LI L, ZIELKE HR, et al: Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 148:121-128, 1996
27. KAI H, IKEDA H, YASUKAWA H, et al: Peripheral blood levels of matrix metalloproteinase-2 and -9 are eleated in patients with acute coronary syndromes. J Am Coll Cardiol 32:368-372, 1998
28. VAN DER WAL AC, BECKER AE, VAN DER LOOS CM, DAS PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36-44, 1994
29. FALK E, SHAH PK, FUSTER V: Coronary plaque disruption. Circulation 92:657-671, 1995
30. BURKE A, FARB A, MALCOM G, et al: Coronary risk factors and plaque morphology in men with coronary disease who die suddenly. N Engl J Med 336:1276-1281, 1997
31. IKEDA U, IKEDA M, OOHARA A, et al: Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol 260 (5 Pt 2):H1713-H1717, 1991
32. ROTH M, NAUCK M, TAMM M, et al: Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells. Proc Natl Acad Sci USA 92:1312-1316, 1995
33. OGUCHI S, DIMAYUGA P, ZHU J, et al: Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 20:1729-1736, 2000
34. O'BRIEN KD, MCDONALD TO, CHAIT A, et al: Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93:672-682, 1996
35. MOULTON KS, VAKILI K, ZURAKOWSKI D, et al: Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atheroeclerosis. Proc Natl Acad Sci USA 100:4736-4741, 2003